Capsaicin-inspired hydroxamate hybrids as selective HDAC6 inhibitors with antiproliferative activity in hematological malignancies (2026)
- Authors:
- Borges, Lara Gimenez
- Alves, Thais Nascimento de Oliveira
- Vassiliades, Sandra Valeria
- Carlos, Jorge Antonio Elias Godoy
- Waitman, Karoline de Barros
- Hilscher, Sebastian
- Schutkowski, Mike
- Sippl, Wolfgang
- Tavares, Maurício Temotheo
- Toledo, Mônica Franco Zannini Junqueira
- Costa-Lotufo, Letícia Veras
- Kronenberger, Thales
- Machado Neto, João Agostinho
- Parise Filho, Roberto
- USP affiliated authors: TOLEDO, MONICA FRANCO ZANNINI JUNQUEIRA - FCF ; LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; PARISE FILHO, ROBERTO - FCF ; BORGES, LARA GIMENEZ - FCF ; ALVES, THAIS NASCIMENTO DE OLIVEIRA - FCF ; VASSILIADES, SANDRA VALERIA - FCF ; CARLOS, JORGE ANTONIO ELIAS GODOY - ICB ; WAITMAN, KAROLINE DE BARROS - FCF
- Unidades: FCF; ICB
- DOI: 10.1021/acsomega.5c11286
- Assunto: FARMACOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2026
- Source:
- Este periódico possui versão em acesso aberto
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão: publishedVersion
- Licença: cc-by
- Evidência: deprecated
- Status do Acesso Aberto: gold
-
ABNT
BORGES, Lara Gimenez et al. Capsaicin-inspired hydroxamate hybrids as selective HDAC6 inhibitors with antiproliferative activity in hematological malignancies. ACS Omega, v. 11, 2026Tradução . . Disponível em: https://doi.org/10.1021/acsomega.5c11286. Acesso em: 10 mar. 2026. -
APA
Borges, L. G., Alves, T. N. de O., Vassiliades, S. V., Carlos, J. A. E. G., Waitman, K. de B., Hilscher, S., et al. (2026). Capsaicin-inspired hydroxamate hybrids as selective HDAC6 inhibitors with antiproliferative activity in hematological malignancies. ACS Omega, 11. doi:10.1021/acsomega.5c11286 -
NLM
Borges LG, Alves TN de O, Vassiliades SV, Carlos JAEG, Waitman K de B, Hilscher S, Schutkowski M, Sippl W, Tavares MT, Toledo MFZJ, Costa-Lotufo LV, Kronenberger T, Machado Neto JA, Parise Filho R. Capsaicin-inspired hydroxamate hybrids as selective HDAC6 inhibitors with antiproliferative activity in hematological malignancies [Internet]. ACS Omega. 2026 ; 11[citado 2026 mar. 10 ] Available from: https://doi.org/10.1021/acsomega.5c11286 -
Vancouver
Borges LG, Alves TN de O, Vassiliades SV, Carlos JAEG, Waitman K de B, Hilscher S, Schutkowski M, Sippl W, Tavares MT, Toledo MFZJ, Costa-Lotufo LV, Kronenberger T, Machado Neto JA, Parise Filho R. Capsaicin-inspired hydroxamate hybrids as selective HDAC6 inhibitors with antiproliferative activity in hematological malignancies [Internet]. ACS Omega. 2026 ; 11[citado 2026 mar. 10 ] Available from: https://doi.org/10.1021/acsomega.5c11286 - Capsaicin inspired hydroxamate hybrids as selective HDAC6 Inhibitors with antiproliferative activity in hematological malignancies
- Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways
- Sulfonamide-based benzyl-hydroxamate derivatives as HDAC6i with potential antitumor activity in hematological lineages
- Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Dona Flor and her two husbands: discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment
- HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents
- Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models
- Design and synthesis of benzodioxol-hydroxamate hybrids as potential anticancer agents
- Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models
- Synthesis and biological evaluation of purine-benzohydroxamates as potential inhibitors of PI3K and HDAC6 for the treatment of hematologic malignancies
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
